会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Methods and devices for collecting and storing clinical samples for genetic analysis
    • 用于收集和存储用于遗传分析的临床样品的方法和装置
    • US06168922A
    • 2001-01-02
    • US09255151
    • 1999-02-22
    • Michael A. HarveyRichard D. KremerRobert L. BurghoffThomas H. King
    • Michael A. HarveyRichard D. KremerRobert L. BurghoffThomas H. King
    • C12Q168
    • C12Q1/6806B01J2219/00639B01J2219/00722C12N15/1003C40B40/06C12Q2565/625C12Q2527/127
    • The present invention relates to devices and methods for the collection, storage, and purification of nucleic acids, such as DNA or RNA, from fluid samples for subsequent genetic characterization, primarily by conventional amplification methods. The present invention can be used to collect, store, or purify nucleic acids either from a biological source other than untreated whole blood, the biological source having naturally occurring nucleic acid amplification inhibitors present, (including either a buccal swab, cerebrospinal fluid, feces, lymphatic fluid, a plasma sample, a saliva sample, a serum sample, urine, or a suspension of cells or viruses), or from a treated whole blood source that has naturally occurring nucleic acid amplification inhibitors present, as well as added blood stabilization components that also inhibit nucleic acid amplification. More importantly, these nucleic acids can be released after collection or storage in a manner that enables them to be amplified by conventional techniques such as polymerase chain reaction. In particular, an absorbent material that does not bind nucleic acids irreversibly is impregnated with a chaotropic salt. A biological source sample is contacted with the impregnated absorbent material. Any nucleic acids present in the biological source can be either eluted or resolubilized off the absorbent material.
    • 本发明涉及用于从流体样品中收集,储存和纯化来自流体样品的核酸的装置和方法,用于随后的遗传表征,主要通过常规的扩增方法。 本发明可用于从除未经处理的全血之外的生物来源收集,储存或纯化核酸,所述生物来源具有天然存在的核酸扩增抑制剂(包括颊拭子,脑脊液,粪便, 淋巴液,血浆样品,唾液样品,血清样品,尿液或细胞或病毒的悬浮液)或来自具有天然存在的核酸扩增抑制剂的处理的全血源,以及添加的血液稳定化成分 这也抑制核酸扩增。 更重要的是,这些核酸可以在收集或储存之后以能够通过常规技术如聚合酶链反应扩增的方式被释放。 特别地,不结合核酸的吸收材料不可逆地浸渍有离液盐。 生物源样品与浸渍的吸收材料接触。 存在于生物来源中的任何核酸都可以从吸收材料中洗脱或再溶解。